Adiposs, the developer of a unique diagnostic product for the non-invasive early detection of body wasting-cachexia, raises CHF 1.8 million in first closing of its Pre-Series A equity round. The round was led by Privilège
Adiposs, the developer of a unique diagnostic product for the non-invasive early detection of body wasting-cachexia, raises CHF 1.8 million in first closing of its Pre-Series A equity round. The round was led by Privilège